Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?-Reference-Cited by-同舟云学术

Cardiovascular risk reduction in hypertension: angiotensin-converting enzyme inhibitors, angiotensin receptor blockers. Where are we up to?

Author:

Sindone A.¹,Erlich J.²³,Lee C.⁴,Newman H.⁵,Suranyi M.⁶,Roger S. D.⁷

Affiliation:

1. Heart Failure Unit and Department of Cardiac Rehabilitation; Concord Repatriation General Hospital; Concord New South Wales Australia

2. Faculty of Medicine; University of NSW; Sydney New South Wales Australia

3. Department of Nephrology; Prince of Wales Hospital; Sydney New South Wales Australia

4. Department of Cardiology; Nepean Hospital; Sydney New South Wales Australia

5. Department of Cardiology; Liverpool Hospital; Sydney New South Wales Australia

6. Liverpool Renal Clinical Research Centre; Liverpool Hospital; Sydney New South Wales Australia

7. Department of Renal Medicine; Gosford Hospital; Gosford New South Wales Australia

Publisher

Wiley

Subject

Internal Medicine

Link

Reference46 articles.

1. National Heart Foundation of Australia 2008 http://www.heartfoundation.org.au/SiteCollectionDocuments/HypertensionGuidelines2008to2010Update.pdf

2. National Vascular Disease Prevention Alliance 2009 http://www.cvdcheck.org.au

3. Medicare Australia http://medicarestatistics.humanservices.gov.au/statistics/pbs_item.jsp

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献